It’s a shame things had to come to this. If only the FDA had had a competent statistician on hand during the original panel review, Genasense would’ve racked up billions and billions of sales during the past few years*.
When I recall how Aventis cleared its salesforce of all other obligations so it could focus entirely in Genasense, it makes my blood boil. Genasense could’ve—and should’ve—been the biggest-selling cancer drug of all time!
*That’s what David Miller said and he should know—no one had his ear closer to the ground.
Market Data 
Markets 
AI
